Biology Reference
In-Depth Information
References
1. Tattersall P (2005) The evolution of parvovirus
taxonomy. In: Kerr JR, Cotmore SF, Bloom
ME, Linden RM, Parrish CR (eds) Parvoviruses.
Hodder Arnold, London, England
2. Hoggan MD (1970) Adenovirus associated
viruses. Prog Med Virol 12:211-239
3. Hoggan MD, Blacklow NR, Rowe WP (1966)
Studies of small DNA viruses found in various
adenovirus preparations: physical, biological,
and immunological characteristics. Proc Natl
Acad Sci USA 55(6):1467-1474
4. Grimm D, Kay MA (2003) From virus evolu-
tion to vector revolution: use of naturally
occurring serotypes of adeno-associated virus
(AAV) as novel vectors for human gene ther-
apy. Curr Gene Ther 3(4):281-304
5. Schmidt M et al (2008) Adeno-associated virus
type 12 (AAV12): a novel AAV serotype with
sialic acid- and heparan sulfate proteoglycan-
independent transduction activity. J Virol
82(3):1399-1406
6. Gao G et al (2004) Clades of Adeno-associated
viruses are widely disseminated in human tis-
sues. J Virol 78(12):6381-6388
7. Gao GP et al (2002) Novel adeno-associated
viruses from rhesus monkeys as vectors for
human gene therapy. Proc Natl Acad Sci USA
99(18):11854-11859
8. Atchison RW, Casto BC, Hammon WM
(1965) Adenovirus-associated defective virus
particles. Science 149:754-756
9. Blacklow NR, Dolin R, Hoggan MD (1971)
Studies of the enhancement of an adenovirus-
associated virus by herpes simplex virus. J Gen
Virol 10(1):29-36
10. Boutin S et al (2010) Prevalence of serum IgG
and neutralizing factors against adeno-
associated virus (AAV) types 1, 2, 5, 6, 8, and 9
in the healthy population: implications for
gene therapy using AAV vectors. Hum Gene
Ther 21(6):704-712
11. Calcedo R, Vandenberghe LH, Gao G, Lin J,
Wilson JM (2009) Worldwide epidemiology of
neutralizing antibodies to adeno-associated
viruses. J Infect Dis 199(3):381-390
12. Erles K, Sebokova P, Schlehofer JR (1999)
Update on the prevalence of serum antibodies
(IgG and IgM) to adeno-associated virus
(AAV). J Med Virol 59(3):406-411
13. Alazard-Dany N et al (2009) Definition of her-
pes simplex virus type 1 helper activities for
adeno-associated virus early replication events.
PLoS Pathog 5(3):e1000340
14. Ward P (2005) Replication of adeno-associated
virus DNA. In: Kerr JR, Cotmore SF, Bloom ME,
Linden RM, Parrish CR (eds) Parvoviruses.
Hodder Arnold, London, England, pp 189-211
15. Kotin RM, Linden RM, Berns KI (1992)
Characterization of a preferred site on human
chromosome 19q for integration of adeno-
associated virus DNA by non-homologous
recombination. EMBO J 11(13):5071-5078
16. Kotin RM et al (1990) Site-specific integration
by adeno-associated virus. Proc Natl Acad Sci
USA 87(6):2211-2215
17. Samulski RJ et al (1991) Targeted integration
of adeno-associated virus (AAV) into human
chromosome 19. EMBO J 10(12):3941-3950
18. Linden RM, Ward P, Giraud C, Winocour E,
Berns KI (1996) Site-specific integration by
adeno-associated virus. Proc Natl Acad Sci
USA 93(21):11288-11294
19. Srivastava A, Lusby EW, Berns KI (1983)
Nucleotide sequence and organization of the
adeno-associated virus 2 genome. J Virol
45(2):555-564
20. Bohenzky RA, LeFebvre RB, Berns KI (1988)
Sequence and symmetry requirements within
the internal palindromic sequences of the
adeno-associated
virus
terminal
repeat.
Virology 166(2):316-327
21. Berns KI, Parrish CR (2007) Parvoviridae. In:
Knipe DM, Howley PM (eds) Fields virology,
vol 2, 5th edn. Lippincott Williams & Wilkins,
Philadelphia, PA, pp 2437-2477
22. Linden RM, Berns KI (2000) Molecular biol-
ogy of adeno-associated viruses. Contrib
Microbiol 4:68-84
23. King JA, Dubielzig R, Grimm D, Kleinschmidt
JA (2001) DNA helicase-mediated packaging of
adeno-associated virus type 2 genomes into pre-
formed capsids. EMBO J 20(12):3282-3291
24. Sonntag F et al (2011) The assembly-activating
protein promotes capsid assembly of different
adeno-associated virus serotypes. J Virol
85(23):12686-12697
25. Summerford C, Samulski RJ (1998)
Membrane-associated heparan sulfate proteo-
glycan is a receptor for adeno-associated virus
type 2 virions. J Virol 72(2):1438-1445
26. Walters RW et al (2001) Binding of adeno-
associated virus type 5 to 2,3-linked sialic acid
is required for gene transfer. J Biol Chem
276(23):20610-20616
27. Kaludov N, Brown KE, Walters RW, Zabner J,
Chiorini JA (2001) Adeno-associated virus
serotype 4 (AAV4) and AAV5 both require
sialic acid binding for hemagglutination and
efficient transduction but differ in sialic acid
linkage specificity. J Virol 75(15):6884-6893
Search WWH ::
Custom Search